Influenza vaccination vaccines, known as flu shots, are vaccines that protect against infection by influenza viruses.
| FactSnippet No. 971,892 |
Influenza vaccination vaccines, known as flu shots, are vaccines that protect against infection by influenza viruses.
| FactSnippet No. 971,892 |
Influenza vaccination vaccines are not recommended in those who have had a severe allergy to previous versions of the vaccine itself.
| FactSnippet No. 971,893 |
The Influenza vaccination program was rushed, yet plagued by delays and public relations problems.
| FactSnippet No. 971,894 |
The effectiveness of flu vaccines is considered to be suboptimal, particularly among the elderly, but vaccination is still beneficial in reducing the mortality rate and hospitalization rate due to influenza as well as duration of hospitalization.
| FactSnippet No. 971,895 |
In working adults, a review by the Cochrane Collaboration found that vaccination resulted in a modest decrease in both influenza symptoms and working days lost, without affecting transmission or influenza-related complications.
| FactSnippet No. 971,896 |
Common side effects of Influenza vaccination include local injection-site reactions and cold-like symptoms.
| FactSnippet No. 971,897 |
Various public health organizations, including the World Health Organization, recommend that yearly influenza vaccination be routinely offered, particularly to people at risk of complications of influenza and those individuals who live with or care for high-risk individuals, including:.
| FactSnippet No. 971,898 |
Influenza vaccination strategy is generally that of protecting vulnerable people, rather than limiting influenza circulation or eliminating human influenza sickness.
| FactSnippet No. 971,899 |
Influenza vaccination's urged eligible people to get COVID-19 and flu vaccines.
| FactSnippet No. 971,900 |
Influenza vaccination vaccines are produced in pathogen-free eggs that are eleven or twelve days old.
| FactSnippet No. 971,901 |
Cost-effectiveness of seasonal influenza vaccination has been widely evaluated for different groups and in different settings.
| FactSnippet No. 971,902 |
In older adults, several published studies have found that influenza vaccination is likely to be cost-effective, however the results of these studies were often found to be dependent on key assumptions used in the economic evaluations.
| FactSnippet No. 971,903 |
In healthy working adults, a 2012 review found that Influenza vaccination was generally not cost-saving, with the suitability for funding being dependent on the willingness to pay to obtain the associated health benefits.
| FactSnippet No. 971,904 |
Influenza vaccination research includes molecular virology, molecular evolution, pathogenesis, host immune responses, genomics, and epidemiology.
| FactSnippet No. 971,905 |